[embedded content]
Céline Gounder, KFF Health News’ editor-at-large for public health, explained on “CBS Mornings” why many at-risk Americans do not know about medication to prevent HIV infection through sexual contact or do not have access to it.
Only one-third of people who could benefit from the medication, known as preexposure prophylaxis or PrEP, are prescribed it, according to the Centers for Disease Control and Prevention.
Céline Gounder:
[email protected]
Related Topics
Contact Us
Submit a Story Tip
Article Attribution | Read More at Article Source
[embedded content]
Céline Gounder, KFF Health News’ editor-at-large for public health, explained on “CBS Mornings” why many at-risk Americans do not know about medication to prevent HIV infection through sexual contact or do not have access to it.
Only one-third of people who could benefit from the medication, known as preexposure prophylaxis or PrEP, are prescribed it, according to the Centers for Disease Control and Prevention.
Céline Gounder:
[email protected]
Related Topics
Contact Us
Submit a Story Tip
nnDiscussion:nn” ai_name=”RocketNews AI: ” start_sentence=”Can I tell you more about this article?” text_input_placeholder=”Type ‘Yes'”]